Sinopharm Group Co. Ltd. (HKG:1099)
17.66
+0.15 (0.86%)
May 19, 2026, 1:05 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 54.64 billion as of May 18, 2026. Its market cap has increased by 0.06% in one year.
Market Cap
54.64B
Enterprise Value
157.35B
Revenue
652.76B
Ranking
n/a
PE Ratio
6.79
Stock Price
17.66
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 54.64B, an increase of 35.17%. That is a compound annual growth rate of 1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 54.64B | -9.93% |
| Dec 31, 2025 | 60.67B | -8.73% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 160 Health International | 6.28B |
| ETHK Labs | 1.41B |
| Sipai Health Technology | 995.12M |
| China Health Group | 707.44M |
| Charmacy Pharmaceutical | 628.56M |
| ClouDr Group | 439.09M |
| Sinco Pharmaceuticals Holdings | 430.97M |
| Wanjia Group Holdings | 211.05M |